Clinical Trial Update: RituxiMab INDuction in Renal Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial update for RituxiMab induction therapy in renal transplantation; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Renal Transplant Dysfunction

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Function of Renal Transplant | Phase 4 | Status: UNKNOWN